At the ICMRA Summit 2025, international medicines authorities addressed the regulators’ role as communicators of reliable, evidence-based, scientific information and the importance of trust and transparency. They highlighted positive examples of reliance pathways saving resources globally and facilitating access. ICMRA members also shared meaningful experiences and perspectives on the role of artificial intelligence (AI) in regulatory practices, and how they can use this transformative technology ethically and responsibly to facilitate access to medicines and innovation.

The Coalition also presented its  annual ICMRA award to Emer Cooke in recognition of her outstanding contribution to international cooperation and the advancement of ICMRA’s mission.

During Emer Cooke’s tenure as ICMRA chair, she has played a key role in guiding the Coalition through a number of public health crises and challenges. Under her leadership, ICMRA has helped spearhead global efforts to…